Mae Funding: How Much Did They Raise & Key Investors

How Much Did Mae Raise?
Funding & Key Investors

Mae, a pioneering digital health platform, has successfully secured a major strategic investment, bringing its total capital accumulation to $1.3M. This latest infusion of $1.3M underscores the growing market confidence in technology-driven solutions designed to address systemic inequities within the maternal healthcare sector. By bridging the gap between Black expectant mothers and essential clinical resources, Mae is positioning itself as a critical infrastructure player in the evolving landscape of reproductive health technology.

The company's trajectory, marked by this significant financing, reflects a broader industry shift toward specialized, culturally competent care models. As Mae continues to scale its operations, the recent capital injection serves as a catalyst for expanding its reach across healthcare payers and state-level partnerships, ensuring that its mission-driven approach to reducing maternal health disparities remains at the forefront of its operational strategy.

What is Mae?

Mae

Software

Healthcare Software

Mae operates as a specialized digital health platform dedicated to improving pregnancy outcomes for Black expectant mothers. By integrating culturally competent care with data-driven resource allocation, the company addresses the profound disparities that persist within the United States healthcare system. Mae functions as a vital intermediary, collaborating with healthcare payers and state agencies to provide comprehensive support systems that mitigate risks associated with systemic healthcare failures. Its market position is defined by its dual focus on clinical efficacy and social equity, making it a unique entity in the digital health ecosystem that prioritizes the needs of historically underserved populations.

How much funding has Mae raised?

Mae has raised a total of $1.3M across 1 funding round:

2021

Angel/Seed

$1.3M

Angel/Seed (2021): $1.3M with participation from MBX Capital, Rhia Ventures, SteelSky Ventures, and Avestria Ventures

Key Investors in Mae

MBX Capital

MBX Capital is a boutique venture capital firm that partners with and creates healthcare and biotechnology companies that are disrupting conventions in service to public health.

Rhia Ventures

Rhia Ventures is dedicated to creating a just reproductive and maternal health market in the United States by engaging investors, activists, innovators, and entrepreneurs.

SteelSky Ventures

SteelSky Ventures is a visionary venture fund focused on investing in companies that enhance access, care, and outcomes in women's health.

What's next for Mae?

With the support of its recent capital, Mae is poised to accelerate its growth trajectory by deepening its integration with existing healthcare infrastructure. The strategic focus will likely shift toward scaling its platform to reach a broader demographic of expectant mothers while simultaneously enhancing its data analytics capabilities to better track and improve maternal health outcomes. By leveraging its current momentum, Mae is well-positioned to influence policy and practice, potentially setting a new standard for how digital health platforms address racial and economic disparities in reproductive care. The company's ability to demonstrate measurable impact will be the primary metric for its future success and potential for further institutional backing.

See full Mae company page

See More Financial Insights